Topics

No keywords indexed for this article. Browse by subject →

References
20
[1]
Sudaka A, Susini A, Lo Nigro C, Fischel JL, Toussan N, Formento P, Tonissi F, Lattanzio L, Russi E, Etienne-Grimaldi MC, Merlano M, Milano G (2013) Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo study. Invest New Drugs 31:59–65. doi:https://doi.org/10.1007/s10637-012-9834-6 10.1007/s10637-012-9834-6
[2]
Papastefanou VO, Cohen VML (2011) Uveal melanoma. J Skin Cancer 2011:573974. doi:https://doi.org/10.1155/2011/573974 10.1155/2011/573974
[3]
Leyvraz S, Keilholz U (2012) Ocular melanoma: what’s new? Curr Opin Oncol 24:162–169. doi:https://doi.org/10.1097/CCO.0b013e32834ff069 10.1097/cco.0b013e32834ff069
[4]
Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW (2005) Functional Analysis of the p53 Pathway in Response to Ionizing Radiation in Uveal Melanoma. Invest Ophthalmol Vis Sci 46:1561–1564. doi:https://doi.org/10.1167/iovs.04-1362 10.1167/iovs.04-1362
[5]
Sheidow TG, Hooper PL, Crukley C, Young J, Heathcote JG (2000) Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophtalmol 84:750–756. doi:https://doi.org/10.1136/bjo.84.7.750 10.1136/bjo.84.7.750
[6]
Boyd SR, Tan DS, Bunce C, Gittos A, Neale MH, Hungerford JL, Charnock-Jones S, Cree IA (2002) Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophtalmol 86:448–452 10.1136/bjo.86.4.448
[7]
Crosby MB, Yang H, Gao W, Zhang L, Grossniklaus HE (2011) Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. Br J Ophthalmol 95:112–117. doi:https://doi.org/10.1136/bjo.2010.182402 10.1136/bjo.2010.182402
[8]
[9]
Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA, van Furth WR (2005) Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines–a clue to radioresistance? J Neurooncol 74:99–103. doi:https://doi.org/10.1007/s11060-004-4204-7 10.1007/s11060-004-4204-7
[10]
The Interleukin-8 Pathway in Cancer

David J.J. Waugh, Catherine Wilson

Clinical Cancer Research 2008 10.1158/1078-0432.ccr-07-4843
[11]
Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI (1991) Structure and functional expression of a human interleukin- 8 receptor. Science 253:1278–1280. doi:https://doi.org/10.1126/science.1840701 10.1126/science.1840701
[12]
Singh S, Nannuru KC, Sadanandam A, Varney ML, Singh RK (2009) CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer 100:1638–1646. doi:https://doi.org/10.1038/sj.bjc.6605055 10.1038/sj.bjc.6605055
[13]
Martin D, Galisteo R, Gutkind S (2009) CXCL8/IL8 stimulates Vascular Endothelial Growth Factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NfkB through the CBM (Carma3/Bcl10/Malt) complex. J Biol Chem 284:6038–6042. doi:https://doi.org/10.1074/jbc.C800207200 10.1074/jbc.c800207200
[14]
Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, Kahnoski N, Futreal PA, Furge KA, Teh BT (2010) Interleukin-8 mediates resistance to anti-angiogenic agent Sunitinib in renal cell carcinoma. Cancer Res 70:1063–1071. doi:https://doi.org/10.1158/0008-5472 10.1158/0008-5472.can-09-3965
[15]
Nagarkatti-Gude N, Bronkhorst IH, van Duinen SG, Luyten GP, Jager MJ (2012) Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci 53:6748–6755. doi:https://doi.org/10.1167/iovs.12-10123 10.1167/iovs.12-10123
[16]
Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47:943–946
[17]
Mantovani G, Maccio A, Mura L, Massa E, Mudu MC, Mulas C et al (2000) Serum levels of leptin and proinflammatory cytokines in patients with advancedstage cancer at different sites. J Mol Med 78:554–561 10.1007/s001090000137
[18]
Crohns M, Saarelainen S, Laine S, Poussa T, Alho H, Kellokumpu-Lehtinen P (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy – Association of interleukin-8 and VEGF with survival. Cytokine 50:30–36. doi:https://doi.org/10.1016/j.cyto.2009.11.017 10.1016/j.cyto.2009.11.017
[19]
Ono M (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99:1501–1506. doi:https://doi.org/10.1111/j.1349-7006.2008.00853 10.1111/j.1349-7006.2008.00853.x
[20]
el Filali M, van der Velden PA, Luyten GP, Jager MJ (2012) Antiangiogenic therapy in uveal melanoma. Dev Ophthalmol 49:117–136. doi:https://doi.org/10.1159/000329591 10.1159/000329591
Metrics
37
Citations
20
References
Details
Published
Oct 01, 2013
Vol/Issue
31(5)
Pages
1107-1114
License
View
Cite This Article
Laura Lattanzio, Federica Tonissi, Ilaria Torta, et al. (2013). Role of IL-8 induced angiogenesis in uveal melanoma. Investigational New Drugs, 31(5), 1107-1114. https://doi.org/10.1007/s10637-013-0005-1